Lv1
2 积分 2026-03-04 加入
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
2个月前
已完结
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
2个月前
已完结
Integrated analysis and functional validation reveal KCNQ1 tumor suppressor targeting by dahuang Zhechong Pills via cuproptosis modulation in colorectal cancer
2个月前
已关闭
Associations between KCNQ1OT1 genetic variation rs10766212 and susceptibility to colorectal cancer and clinical stage in a Chinese Han population
2个月前
已完结
miR-483-5p promotes esophageal cancer progression by targeting KCNQ1
2个月前
已完结
Adrenomedullin/ FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis
2个月前
已完结
Traditional Chinese Medicine Formulas-Based Interventions on Colorectal Carcinoma Prevention: The Efficacies, Mechanisms and Advantages
2个月前
已完结
Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments
2个月前
已完结
皖公网安备34019202002308
